TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.01% | 8.30% | -2.62% | 6.08% | 3.18% |
| Total Depreciation and Amortization | -5.91% | -3.64% | -0.20% | 15.88% | 23.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.25% | 7.19% | 7,768.93% | 1,451.13% | 1,279.41% |
| Change in Net Operating Assets | 146.33% | 138.11% | 130.75% | 82.11% | -65.13% |
| Cash from Operations | 8.80% | 19.69% | 32.16% | 31.55% | 20.78% |
| Capital Expenditure | 9.77% | 25.38% | 54.70% | 33.23% | 43.52% |
| Sale of Property, Plant, and Equipment | 151.42% | 134.92% | -76.21% | -79.83% | -89.55% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3,010.00% | 939.25% | -80.99% | -89.57% | -99.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.40% | -72.40% | -72.53% | 7,972.23% | 8,659.55% |
| Repurchase of Common Stock | 43.33% | 50.92% | 44.44% | 41.44% | 39.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.41% | -40.38% | -40.20% | 24,936.84% | 29,682.64% |
| Foreign Exchange rate Adjustments | 111.30% | 28.29% | -875.00% | 100.00% | -2,046.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.45% | -158.12% | -130.97% | 130.51% | 122.03% |